Free Trial
NASDAQ:APDN

Applied DNA Sciences (APDN) Stock Price, News & Analysis

Applied DNA Sciences logo
$2.04 +0.30 (+17.07%)
As of 03:14 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Applied DNA Sciences Stock (NASDAQ:APDN)

Key Stats

Today's Range
$1.67
$1.95
50-Day Range
$0.05
$2.26
52-Week Range
$1.68
$522.00
Volume
3.05 million shs
Average Volume
128,397 shs
Market Capitalization
$2.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$75.00
Consensus Rating
Buy

Company Overview

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Remove Ads

Applied DNA Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
39th Percentile Overall Score

APDN MarketRank™: 

Applied DNA Sciences scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Applied DNA Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Applied DNA Sciences has received no research coverage in the past 90 days.

  • Read more about Applied DNA Sciences' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Applied DNA Sciences is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Applied DNA Sciences is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Applied DNA Sciences has a P/B Ratio of 6.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Applied DNA Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    5.45% of the float of Applied DNA Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Applied DNA Sciences has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Applied DNA Sciences has recently decreased by 46.52%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Applied DNA Sciences does not currently pay a dividend.

  • Dividend Growth

    Applied DNA Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.45% of the float of Applied DNA Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Applied DNA Sciences has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Applied DNA Sciences has recently decreased by 46.52%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Applied DNA Sciences has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Industrial Products companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Applied DNA Sciences this week, compared to 1 article on an average week.
  • Search Interest

    Only 4 people have searched for APDN on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.17% of the stock of Applied DNA Sciences is held by insiders.

  • Percentage Held by Institutions

    Only 22.22% of the stock of Applied DNA Sciences is held by institutions.

  • Read more about Applied DNA Sciences' insider trading history.
Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

APDN Stock News Headlines

Applied DNA Sciences trading halted, news pending
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."
If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.
Applied DNA Sciences announces 1-for-50 reverse stock split
See More Headlines

APDN Stock Analysis - Frequently Asked Questions

Applied DNA Sciences' stock was trading at $10.20 at the start of the year. Since then, APDN stock has decreased by 81.9% and is now trading at $1.8450.
View the best growth stocks for 2025 here
.

Applied DNA Sciences, Inc. (NASDAQ:APDN) released its earnings results on Thursday, February, 13th. The technology company reported ($28.00) earnings per share (EPS) for the quarter, missing the consensus estimate of ($16.00) by $12.00. Applied DNA Sciences had a negative trailing twelve-month return on equity of 101.57% and a negative net margin of 228.12%.

Applied DNA Sciences's stock reverse split on the morning of Thursday, April 25th 2024. The 1-20 reverse split was announced on Thursday, April 25th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, April 25th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Applied DNA Sciences' top institutional shareholders include Geode Capital Management LLC (0.76%), Connective Capital Management LLC (0.32%), Millennium Management LLC (0.24%) and Concourse Financial Group Securities Inc..
View institutional ownership trends
.

Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Applied DNA Sciences investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), Virgin Galactic (SPCE), AST SpaceMobile (ASTS) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
2/13/2025
Today
3/19/2025
Next Earnings (Estimated)
5/09/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Testing laboratories
Sub-Industry
Business Services
Current Symbol
NASDAQ:APDN
Employees
70
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$75.00
High Stock Price Target
$75.00
Low Stock Price Target
$75.00
Potential Upside/Downside
+4,210.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-6,990,000.00
Net Margins
-228.12%
Pretax Margin
-230.79%

Debt

Sales & Book Value

Annual Sales
$3.74 million
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
6.00

Miscellaneous

Free Float
55,095,000
Market Cap
$1.92 million
Optionable
Optionable
Beta
0.43
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (NASDAQ:APDN) was last updated on 3/19/2025 by MarketBeat.com Staff
From Our Partners